Biotech | November 30, 2021
Galderma acquires ALASTIN Skincare to enhance its dermatology platform
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
Sciflix is a special Initiative by Lupin to assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality
The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases
Maharashtra won the award for the highest number of deceased donors transplantations
A first for the Asian market, addressing the health spends needs of over 200 million households.
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
Subscribe To Our Newsletter & Stay Updated
